Research suggests that elderberry-based syrup formulations may help modulate inflammatory responses in immune cells, based on a single in vitro laboratory study testing commercial elderflower-containing syrups on human macrophages. The available evidence consists of one cell-based study — not a clinical trial involving human participants — which found that two elderflower and beta-glucan syrup formulations reduced the release of pro-inflammatory molecules when immune cells were artificially stimulated. While the researchers noted potential relevance to conditions such as recurrent respiratory infections, findings from cell studies do not necessarily translate to effects observed in living humans, and the mixed designation of this study reflects the inherent limitations of drawing conclusions from laboratory models alone. Overall, the current evidence base is very limited, and well-designed human clinical trials would be needed before stronger conclusions about effectiveness can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Evaluation of anti-inflammatory and immunoregulatory activities of Stimunex® ... | Other | 2020 | Mixed | 72 |